The Impact of Erythropoietin on Short and Long-term Kidney-Related Outcomes in Extremely Low Gestational Age Neonates. Results of a Multi-center Double-Blind Placebo-Controlled Randomized Clinical Trial

OBJECTIVE: To evaluate whether extremely low gestational age neonates (ELGANs) randomized to erythropoietin have better or worse kidney-related outcomes during hospitalization and at 22–26 months corrected gestational age (cGA) compared with those randomized to placebo. STUDY DESIGN: We performed an...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Pediatr
Asıl Yazarlar: Askenazi, David J., Heagerty, Patrick J., Schmicker, Robert H., Brophy, Patrick, Juul, Sandra E., Goldstein, Stuart L., Hingorani, Sangeeta
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8093092/
https://ncbi.nlm.nih.gov/pubmed/33484699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2021.01.031
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller